Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Díaz-Simón

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|May 23, 2002
Priapism associated with zuclopenthixolJulio Salado, Antonio Blázquez, Raquel Díaz-Simón, et al.
Frontiers in Immunology|April 29, 2021
Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid SyndromeDaniel E Pleguezuelo, Raquel Díaz-Simón, Oscar Cabrera-Marante, et al.
Journal of Digestive Diseases|September 28, 2022
Sporadic, non-functional, gastrin-producing duodenal neuroendocrine tumors: A retrospective study of an infrequent diseaseLucía de Jorge Huerta, Isabel Solares Fernández, Beatriz Sánchez-Moreno, et al.
Journal of Thrombosis and Thrombolysis|June 7, 2018
Impact of functional status on 6-month mortality in elderly patients with acute venous thromboembolism: results from a prospective cohortCovadonga Gómez-Cuervo, Carmen Díaz-Pedroche, María Asunción Pérez-Jacoiste Asín, et al.
Frontiers in Cardiovascular Medicine|May 20, 2021
Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic StrokeLaura Naranjo, Fernando Ostos, Francisco Javier Gil-Etayo, et al.
Biomedicines|August 27, 2021
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting ActorFrancisco Javier Gil-Etayo, Sara Garcinuño, Antonio Lalueza, et al.
International Journal of Molecular Sciences|June 24, 2022
Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 EvolutionSara Garcinuño, Francisco Javier Gil-Etayo, Esther Mancebo, et al.
Frontiers in Cellular and Infection Microbiology|March 15, 2021
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 ProgressionFrancisco Javier Gil-Etayo, Patricia Suàrez-Fernández, Oscar Cabrera-Marante, et al.
Frontiers in Immunology|August 18, 2025
Criteria and non-criteria anti-phospholipid antibodies in the different clinical forms of antiphospholipid syndromeOscar Cabrera-Marante, Daniel Pleguezuelo, Sara Garcinuño, et al.
Frontiers in Immunology|August 23, 2024
Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosisSara Garcinuño, Antonio Lalueza, Francisco Javier Gil-Etayo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|May 23, 2002
Priapism associated with zuclopenthixolJulio Salado, Antonio Blázquez, Raquel Díaz-Simón, et al.
Frontiers in Immunology|April 29, 2021
Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid SyndromeDaniel E Pleguezuelo, Raquel Díaz-Simón, Oscar Cabrera-Marante, et al.
Journal of Digestive Diseases|September 28, 2022
Sporadic, non-functional, gastrin-producing duodenal neuroendocrine tumors: A retrospective study of an infrequent diseaseLucía de Jorge Huerta, Isabel Solares Fernández, Beatriz Sánchez-Moreno, et al.
Journal of Thrombosis and Thrombolysis|June 7, 2018
Impact of functional status on 6-month mortality in elderly patients with acute venous thromboembolism: results from a prospective cohortCovadonga Gómez-Cuervo, Carmen Díaz-Pedroche, María Asunción Pérez-Jacoiste Asín, et al.
Frontiers in Cardiovascular Medicine|May 20, 2021
Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic StrokeLaura Naranjo, Fernando Ostos, Francisco Javier Gil-Etayo, et al.
Biomedicines|August 27, 2021
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting ActorFrancisco Javier Gil-Etayo, Sara Garcinuño, Antonio Lalueza, et al.
International Journal of Molecular Sciences|June 24, 2022
Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 EvolutionSara Garcinuño, Francisco Javier Gil-Etayo, Esther Mancebo, et al.
Frontiers in Cellular and Infection Microbiology|March 15, 2021
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 ProgressionFrancisco Javier Gil-Etayo, Patricia Suàrez-Fernández, Oscar Cabrera-Marante, et al.
Frontiers in Immunology|August 18, 2025
Criteria and non-criteria anti-phospholipid antibodies in the different clinical forms of antiphospholipid syndromeOscar Cabrera-Marante, Daniel Pleguezuelo, Sara Garcinuño, et al.
Frontiers in Immunology|August 23, 2024
Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosisSara Garcinuño, Antonio Lalueza, Francisco Javier Gil-Etayo, et al.
Pageof 2